Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ CLEC2D Polyclonal Antibody
GREENER_CHOICE

Catalog No. PIPA547496
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PIPA547496 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. PIPA547496 Supplier Invitrogen™ Supplier No. PA547496
Add to Cart
Edge
Add to Cart

Goat Polyclonal Antibody

In Western blots, approximately 15% cross-reactivity with recombinant mouse (rm) OCIL is observed and less than 1% cross-reactivity with rmOCILrp2, recombinant human (rh) CLEC4D, and rhCLEC4F is observed. Reconstitute at 0.2 mg/mL in sterile PBS.

Recently, Zhou et al have identified a protein that can inhibit multinucleate Osteoclast formation in murine osteoblast and spleen cell co-cultures. This protein called, Osteoclast Inhibitory Lectin (OCIL) can also inhibit osteoclast formation in spleen cell cultures treated with RANKL and M-CSF. Furthermore, mOCIL acted directly on macrophage/monocyte cells as evidenced by its inhibitory action on adherent spleen cell cultures, which were depleted of stromal and lymphocytic cells. mOCIL completely inhibited osteoclast formation during the proliferative phase of osteoclast formation and resulted in 70% inhibition during the differentiation phase. Osteoblast OCIL mRNA expression was enhanced by parathyroid hormone, calcitriol, interleukin-1 and IL-11, and retinoic acid. OCIL is expressed in osteoblasts and chondrocytes as well as in a variety of extraskeletal tissues. Since OCIL expression was found to be very similar to distribution for RANKL, it has been suggested that RANKl and OCIL may interact in skeleton and in extracellular tissues.
TRUSTED_SUSTAINABILITY

Specifications

Antigen CLEC2D
Applications Flow Cytometry, Western Blot
Classification Polyclonal
Concentration 0.2 mg/mL
Conjugate Unconjugated
Formulation PBS with 5% trehalose and No Preservative
Gene CLEC2D
Gene Accession No. Q9UHP7
Gene Alias CLAX; Clec2d; Clrb; Clr-b; C-type lectin domain family 2 member D; C-type lectin domain family 2, member d; C-type lectin related f; C-type lectin superfamily 2, member D; C-type lectin-domain family 2 member D; C-type lectin-related protein B; lectin-like NK cell receptor; Lectin-like transcript 1; lectin-like transmembrane protein; LLT1; LLT-1; MGC123478; OCIL; Osteoclast inhibitory lectin
Gene Symbols CLEC2D
Host Species Goat
Immunogen E. coli-derived recombinant human OCIL/CLEC2d Ser57-Val191.
Purification Method Antigen affinity chromatography
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 29121
Target Species Human
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Lyophilized
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.